Investigation of LL-37-mediated siRNA transfection

RNA interference is not only an important tool for studying protein function; it also holds many promises for the treatment of a variety of diseases in which the function of unwanted proteins needs to be suppressed. For small interfering RNA (siRNA) to be used as a therapeutic agent, the biggest hurdle is to find the right delivery agent that is both nontoxic to the cells and efficient in delivery. Synthetic and natural peptides from a variety of organisms have been investigated for this purpose. However, there is still no agent or formulation that has been approved for siRNA delivery. Antimicrobial peptide LL-37 has been reported to deliver negatively charged cargo molecules like DNA into the mammalian cells. Since it is nontoxic and nonimmunogenic, and it has the ability to penetrate through mammalian cells in complex with negatively charged molecules, LL-37 peptide appears to make an ideal delivery agent for siRNA therapy. In this report, LL-37/siRNA complexes have been characterized and LL-37-mediated transfection has been investigated in vitro. The results show that the efficiency of delivery was dependent on the cell type, and for LL-37 to be used as a siRNA delivery agent, conditions have to be optimized for each target tissue type.

Anahtar Kelimeler:

Key words: Antimicrobial peptide, LL-37, siRNA, shRNA, transfection, cell-penetrating peptides

Investigation of LL-37-mediated siRNA transfection

Keywords:

Key words: Antimicrobial peptide, LL-37, siRNA, shRNA, transfection, cell-penetrating peptides,

PDF

___

Fire A, Xu S, Montgomery MK et al. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 6669: 806–811, 1998.
Wianny F, Zernicka-Goetz M. Specific interference with gene function by double-stranded RNA in early mouse development. Nat Cell Biol 2: 70–75, 2000.
Elbashir SM, Harborth J, Lendeckel W et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411: 494–498, 2001.
Castanotto D, Rossi JJ. The promises and pitfalls of RNAinterference-based therapeutics. Nature 457: 426–433, 2009.
Zhao Y, Srivastava D. A developmental view of microRNA function. Trends Biochem Sci 32: 189–197, 2007.
Chiu YL, Ali A, Chu CY et al. Visualizing a correlation between siRNA localization, cellular uptake, and RNAi in living cells. Chem Biol 11: 1165–1175, 2004.
Soutschek J, Akinc A, Bramlage B et al. Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs. Nature 432: 173–178, 2004.
Itaka K, Kataoka K. Recent development of nonviral gene delivery systems with virus-like structures and mechanisms. Eur J Pharm Biopharm 71: 475–483, 2009.
Lares MR, Rossi JJ, Ouellet DL. RNAi and small interfering RNAs in human disease therapeutic applications. Trends Biotechnol 11: 570–579, 2010.
Singh SK, Hajeri PB. siRNAs: their potential as therapeutic agents--Part II. Methods of delivery. Drug Discov Today 14: 859–865, 2009.
Fonseca SB, Pereira MP, Kelley SO. Recent advances in the use of cell-penetrating peptides for medical and biological applications. Adv Drug Deliver Rev 61: 953–964, 2009.
Frankel AD, Pabo CO. Cellular uptake of the tat protein from human immunodeficiency virus. Cell 55: 1189–1193, 1988.
Eguchi A, Akuta T, Okuyama H. Protein transduction domain of HIV-1 Tat protein promotes efficient delivery of DNA into mammalian cells. J Biol Chem 276: 26204–26210, 2001.
Fawell S, Seery J, Daikh Y et al. Tat-mediated delivery of heterologous proteins into cells. P Natl Acad Sci USA 91: 664– 668, 1994.
Santra S, Yang H, Stanley JT et al. Rapid and effective labeling of brain tissue using TAT-conjugated CdS:Mn/ZnS quantum dots. Chem Commun 25: 3144–3146, 2005.
Sİrensen OE, Follin P, Johnsen AH et al. Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3. Blood 97: 3951–3959, 200
Larrick JW, Hirata M, Balint RF et al. Human CAP18: a novel antimicrobial lipopolysaccharide binding protein. Infect Immun 63: 1291–1297, 1995.
Sİrensen O, Cowland JB, Askaa J et al. An ELISA for hCAP-18, the cathelicidin present in human neutrophils and plasma. J Immunol Methods 206: 53–59, 1997.
Sandgren S, Wittrup A, Cheng F et al. The human antimicrobial peptide LL-37 transfers extracellular DNA plasmid to the nuclear compartment of mammalian cells via lipid rafts and proteoglycan-dependent endocytosis. J Biol Chem 279: 17951– 17956, 2004.
Lande R, Gregorio J, Facchinetti V et al. Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature 449: 564–569, 2007.
Felgner PL, Barenholz Y, Behr JP et al. Nomenclature for synthetic gene delivery systems. Hum Gene Ther 8: 511–512, 19 Chamilos G, Gregorio J, Meller S et al. Cytosolic sensing of extracellular self-DNA transported into monocytes by the antimicrobial peptide LL37. Blood 120: 3699–3707, 2012.
Lo SL, Wang S. An endosomolytic Tat peptide produced by incorporation of histidine and cysteine residues as a nonviral vector for DNA transfection. Biomaterials 29: 2408–2414, 200